DURECT Corp (NASDAQ:DRRX)
| 2.51 Delayed Data As of Sep 29 |  +0.04 / +1.62%Today’s Change | 2.41 Today|||52-Week Range 9.50 | -27.46% Year-to-Date |
Latest DRRX News | Press Releases
No recent news for DURECT Corp.
Today’s Trading
| Previous close | 2.47 |
| Today’s open | 2.50 |
| Day’s range | 2.42 - 2.51 |
| Volume | 11,582 |
| Average volume (3 months) | 216,970 |
| Market cap | $68.4M |
Data as of 3:59pm ET, 09/29/2023
Growth & Valuation
| Earnings growth (last year) | +3.73% |
| Earnings growth (this year) | -15.81% |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | +37.96% |
| P/E ratio | NM |
| Price/Sales | 4.09 |
| Price/Book | 2.26 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ZYNEZynerba Pharmaceutic... | -0.01 | -0.78% |
| ---- | ||
| ---- | ||
| OCUPOcuphire Pharma Inc | -0.14 | -4.02% |
Data as of 4:00pm ET, 09/29/2023
Financials
| Next reporting date | November 6, 2023 |
| EPS forecast (this quarter) | -$0.47 |
| Annual revenue (last year) | $19.3M |
| Annual profit (last year) | -$35.3M |
| Net profit margin | -183.23% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Cupertino, California |
Forecasts
